OTC Pharmaceuticals - United Arab Emirates

  • United Arab Emirates
  • Revenue in the OTC Pharmaceuticals market amounts to US$651.60m in 2024. The market is expected to grow annually by 4.58% (CAGR 2024-2029).
  • The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of US$177.80m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$67.94 are generated in 2024.
  • In the OTC Pharmaceuticals market, 22.9% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in United Arab Emirates is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the current state of the market.

Customer preferences:
In United Arab Emirates, customers have shown a growing preference for self-medication and easy access to healthcare products. This has led to an increased demand for over-the-counter (OTC) pharmaceuticals. Customers are seeking convenience and affordability, and OTC medicines provide them with the opportunity to treat minor ailments without the need for a prescription or a visit to a healthcare professional. The convenience of purchasing OTC medicines from pharmacies and supermarkets further adds to their appeal.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in United Arab Emirates is the increasing availability and variety of OTC products. Pharmacies and supermarkets are expanding their range of OTC medicines to cater to the growing demand. This includes a wide range of products for common ailments such as cold and flu, allergies, pain relief, and digestive issues. Additionally, there is a growing trend towards natural and herbal remedies, as customers are becoming more health-conscious and seeking alternatives to traditional medicines. Another trend in the market is the rising popularity of online pharmacies. With the increasing use of e-commerce platforms, customers now have the option to purchase OTC medicines online and have them delivered to their doorstep. This provides added convenience and accessibility, particularly for customers who may have difficulty visiting physical stores.

Local special circumstances:
United Arab Emirates has a rapidly growing population, which is contributing to the increased demand for OTC pharmaceuticals. The country is also known for its high standard of healthcare and a strong emphasis on preventive care. This has led to a proactive approach towards self-medication and the use of OTC medicines as a means of maintaining good health. Additionally, the country has a large expatriate population, which further drives the demand for OTC medicines as these individuals may be more familiar with self-medication practices from their home countries.

Underlying macroeconomic factors:
The OTC Pharmaceuticals market in United Arab Emirates is influenced by various macroeconomic factors. The country has a strong economy and a high per capita income, which allows consumers to afford OTC medicines. Additionally, the government has implemented policies to promote the growth of the healthcare sector, including the expansion of healthcare infrastructure and the encouragement of private sector investments. These factors contribute to the overall development and expansion of the OTC Pharmaceuticals market in United Arab Emirates. In conclusion, the OTC Pharmaceuticals market in United Arab Emirates is experiencing growth and development due to customer preferences for self-medication and convenience, the availability of a wide range of OTC products, the rising popularity of online pharmacies, the local emphasis on preventive care, and the underlying macroeconomic factors such as a strong economy and government support for the healthcare sector. These factors are driving the increasing demand for OTC medicines in United Arab Emirates.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)